← Back to Clinical Trials
Recruiting NCT05268861

NCT05268861 The Role of Cognition in Motor Learning After Stroke

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT05268861
Status Recruiting
Phase
Sponsor McGill University
Condition Stroke Hemorrhagic
Study Type INTERVENTIONAL
Enrollment 24 participants
Start Date 2022-04-01
Primary Completion 2026-07

Eligibility & Interventions

Sex All sexes
Min Age 40 Years
Max Age 75 Years
Study Type INTERVENTIONAL
Interventions
Error Augmentation FeedbackNo Error Augmentation Feedback

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 24 participants in total. It began in 2022-04-01 with a primary completion date of 2026-07.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

Stroke leads to lasting problems in using the upper limb (UL) for everyday life activities. While rehabilitation programs depend on motor learning, UL recovery is less than ideal. Implicit learning is thought to lead to better outcomes than explicit learning. Cognitive factors (e.g., memory, attention, perception), essential to implicit motor learning, are often impaired in people with stroke. The objective of this study is to investigate the role of cognitive deficits on implicit motor learning in people with stroke. The investigators hypothesize that 1) subjects with stroke will achieve better motor learning when training with additional intrinsic feedback compared to those who train without additional intrinsic feedback, and 2) individuals with stroke who have cognitive deficits will have impairments in their ability to use feedback to learn a motor skill compared to individuals with stroke who do not have cognitive deficits. A recent feedback modality, called error augmentation (EA), can be used to enhance motor learning by providing subjects with magnified motor errors that the nervous system can use to adapt performance. The investigators will use a custom-made training program that includes EA feedback in a virtual reality (VR) environment in which the range of the UL movement is related to the patient's specific deficit in the production of active elbow extension. An avatar depiction of the arm will include a 15 deg elbow flexion error to encourage subjects to increase elbow extension beyond the current limitations. Thus, the subject will receive feedback that the elbow has extended less than it actually has and will compensate by extending the elbow further. Subjects will train for 30 minutes with the EA program 3 times a week for 9 weeks. Kinematic and clinical measures will be recorded before, after 3 weeks, after 6 weeks, and after 9 weeks. Four weeks after the end of training, there will be a follow-up evaluation. Imaging scans will be done to determine lesion size and extent, and descending tract integrity with diffusion tensor imaging (DTI). This study will identify if subjects with cognitive deficits benefit from individualized training programs using enhanced intrinsic feedback. The development of treatments based on mechanisms of motor learning can move rehabilitation therapy in a promising direction by allowing therapists to design more effective interventions for people with problems using their upper limb following a stroke.

Eligibility Criteria

Inclusion Criteria: * Sustained a first cortical/sub-cortical ischemic/hemorrhagic stroke less than 3 years previously and are medically stable. * Are no longer receiving treatment. * Normal or corrected-to-normal vision. * Have arm paresis (Chedoke-McMaster Arm Scale 2-6/7) and spasticity (Modified Ashworth Scale ≥ 1/4) but can voluntarily flex/extend the elbow to approximately 30 degrees in each direction. Exclusion Criteria: * Other major neurological or musculoskeletal problems that may interfere with task performance. * Marked elbow proprioceptive deficits (\<6/12 Fugl-Meyer UL sensation scale) that may interfere with elbow position perception. * Visuospatial neglect (Line Bisection Test deviation \> 6 mm). * Uncorrected vision. * Depression (≥ 14 Beck Depression Inventory II).

Contact & Investigator

Central Contact

Mindy Levin, PhD, PT

✉ mindy.levin@mcgill.ca

📞 (450) 688-9550

Principal Investigator

Mindy Levin, PhD, PT

PRINCIPAL INVESTIGATOR

McGill University

Frequently Asked Questions

Who can join the NCT05268861 clinical trial?

This trial is open to participants of all sexes, aged 40 Years or older, up to 75 Years, studying Stroke Hemorrhagic. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT05268861 currently recruiting?

Yes, NCT05268861 is actively recruiting participants. Contact the research team at mindy.levin@mcgill.ca for enrollment information.

Where is the NCT05268861 trial being conducted?

This trial is being conducted at Laval, Canada.

Who is sponsoring the NCT05268861 clinical trial?

NCT05268861 is sponsored by McGill University. The principal investigator is Mindy Levin, PhD, PT at McGill University. The trial plans to enroll 24 participants.

Related Trials

Related Intelligence Guides

In-depth guides covering this condition's trials, eligibility, and what to expect.

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology